Metastatic CRPC: Advent of PARP Inhibitors

Comprehensive insight on the evolving role of PARP inhibitors in metastatic castration-resistant prostate cancer and clinical trials in this setting.

Related Keywords

,Key Updates ,Metastatic Prostate Cancer Treatment ,Prostate Cancer ,Metastatic Castration Resistant Prostate Cancer ,Castration Resistant Prostate Cancer ,Nmcrpc ,Crpc ,Parp Inhibition ,Parp Inhibitors ,Olaparib ,Abiraterone ,Niraparib ,Talazoparib ,Enzalutamide ,Rucaparib ,Novel Therapy ,Combination Therapy ,Doublet Therapy ,Propel Trial ,Propel Study ,Magnitude Trial ,Magnitude Study ,Talapro 2 ,Triton3 ,